Author:
Manning-Geist Beryl L.,Chi Dennis S.,Long Roche Kara,Zivanovic Oliver,Sonoda Yukio,Gardner Ginger J.,O'Cearbhaill Roisin E.,Abu-Rustum Nadeem R.,Leitao Mario M.
Subject
Obstetrics and Gynecology,Oncology
Reference17 articles.
1. Guidelines and selection criteria for secondary cytoreductive surgery in patients with recurrent, platinum-sensitive epithelial ovarian carcinoma;Chi;Cancer.,2006
2. Randomized phase III study to evaluate the impact of secondary cytoreductive surgery in recurrent ovarian cancer: final analysis of AGO DESKTOP III/ENGTO-ov20;Du Bois;J. Clin. Oncol.,2020
3. Secondary cytoreduction followed by chemotherapy versus chemotherapy alone in platinum-sensitive relapsed ovarian cancer (SOC-1): a multicentre, open-label, randomised, phase 3 trial;Shi;Lancet Oncol.,2021
4. Secondary surgical cytoreduction for recurrent ovarian cancer;Coleman;N. Engl. J. Med.,2019
5. Tertiary cytoreduction in patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer: an updated series;Shih;Gynecol. Oncol.,2010